Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bharat Biotech International Limited

Clinical trials sponsored by Bharat Biotech International Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New chikungunya vaccine trial aims to protect millions Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New TB vaccine candidate MTBVAC enters Mid-Stage human trial

Vaccine Ongoing

This phase II trial tests a new tuberculosis vaccine called MTBVAC (BBV169) in 164 healthy adolescents and adults. Some participants get the new vaccine, others get the standard BCG vaccine. The study checks how safe the vaccine is and how well it triggers an immune response, aim…

Phase 2 • Sponsor: Bharat Biotech International Limited • Aim: Vaccine

Last updated Jun 27, 2026 12:25 UTC